Fibrous dysplasia as a possible false-positive finding in 68Ga-labeled prostate-specific membrane antigen positron emission tomography/computed tomography study in the follow-up of prostate cancer

Positron emission tomography/computed tomography (PET/CT) using 68Ga-labeled prostate-specific membrane antigen (68Ga-PSMA) has become an important tool in restaging patients with prostate cancer (PCa). Despite its high sensitivity and specificity, this method may produce false-positive findings, as...

Full description

Saved in:
Bibliographic Details
Main Authors: André Marcondes Braga Ribeiro, Eduardo Nóbrega Pereira Lima, Maurìcio Murce Rocha
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-10-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_111_18
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850251363508813824
author André Marcondes Braga Ribeiro
Eduardo Nóbrega Pereira Lima
Maurìcio Murce Rocha
author_facet André Marcondes Braga Ribeiro
Eduardo Nóbrega Pereira Lima
Maurìcio Murce Rocha
author_sort André Marcondes Braga Ribeiro
collection DOAJ
description Positron emission tomography/computed tomography (PET/CT) using 68Ga-labeled prostate-specific membrane antigen (68Ga-PSMA) has become an important tool in restaging patients with prostate cancer (PCa). Despite its high sensitivity and specificity, this method may produce false-positive findings, as indicated by previous studies. This case report aims to warn nuclear medicine physicians, oncologists, and urologists about the possibility of false-positive findings using this imaging modality, especially when the detected site is unusual for bone metastasis. A 68-year-old man with PCa underwent restaging tests after presenting with increased prostate-specific antigen.68Ga-PSMA PET/CT imaging revealed abnormal uptake in the left humeral head, which anatomically corresponded to the intramedullary and cortical sclerotic area. A biopsy was performed, and the pathology showed a lesion consisting of hard bone tissue with a small focal spot of fibrous dysplasia. Diagnostic issues related to 68Ga-PSMA PET/CT imaging should be disseminated to help physicians make appropriate treatment choices for each patient.
format Article
id doaj-art-7790da46a632499890ae7b3f4e33f228
institution OA Journals
issn 1450-1147
1607-3312
language English
publishDate 2019-10-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series World Journal of Nuclear Medicine
spelling doaj-art-7790da46a632499890ae7b3f4e33f2282025-08-20T01:57:55ZengThieme Medical and Scientific Publishers Pvt. Ltd.World Journal of Nuclear Medicine1450-11471607-33122019-10-01180440941210.4103/wjnm.WJNM_111_18Fibrous dysplasia as a possible false-positive finding in 68Ga-labeled prostate-specific membrane antigen positron emission tomography/computed tomography study in the follow-up of prostate cancerAndré Marcondes Braga Ribeiro0Eduardo Nóbrega Pereira Lima1Maurìcio Murce Rocha2Department of Nuclear Medicine, A. C. Camargo Cancer Center, São Paulo, BrazilDepartment of Nuclear Medicine, A. C. Camargo Cancer Center, São Paulo, BrazilDepartment of Urology, A. C. Camargo Cancer Center, São Paulo, BrazilPositron emission tomography/computed tomography (PET/CT) using 68Ga-labeled prostate-specific membrane antigen (68Ga-PSMA) has become an important tool in restaging patients with prostate cancer (PCa). Despite its high sensitivity and specificity, this method may produce false-positive findings, as indicated by previous studies. This case report aims to warn nuclear medicine physicians, oncologists, and urologists about the possibility of false-positive findings using this imaging modality, especially when the detected site is unusual for bone metastasis. A 68-year-old man with PCa underwent restaging tests after presenting with increased prostate-specific antigen.68Ga-PSMA PET/CT imaging revealed abnormal uptake in the left humeral head, which anatomically corresponded to the intramedullary and cortical sclerotic area. A biopsy was performed, and the pathology showed a lesion consisting of hard bone tissue with a small focal spot of fibrous dysplasia. Diagnostic issues related to 68Ga-PSMA PET/CT imaging should be disseminated to help physicians make appropriate treatment choices for each patient.http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_111_18 68ga-labeled prostate-specific membrane antigenbone metastasisfalse-positive resultfibrous dysplasiaprostate cancer
spellingShingle André Marcondes Braga Ribeiro
Eduardo Nóbrega Pereira Lima
Maurìcio Murce Rocha
Fibrous dysplasia as a possible false-positive finding in 68Ga-labeled prostate-specific membrane antigen positron emission tomography/computed tomography study in the follow-up of prostate cancer
World Journal of Nuclear Medicine
68ga-labeled prostate-specific membrane antigen
bone metastasis
false-positive result
fibrous dysplasia
prostate cancer
title Fibrous dysplasia as a possible false-positive finding in 68Ga-labeled prostate-specific membrane antigen positron emission tomography/computed tomography study in the follow-up of prostate cancer
title_full Fibrous dysplasia as a possible false-positive finding in 68Ga-labeled prostate-specific membrane antigen positron emission tomography/computed tomography study in the follow-up of prostate cancer
title_fullStr Fibrous dysplasia as a possible false-positive finding in 68Ga-labeled prostate-specific membrane antigen positron emission tomography/computed tomography study in the follow-up of prostate cancer
title_full_unstemmed Fibrous dysplasia as a possible false-positive finding in 68Ga-labeled prostate-specific membrane antigen positron emission tomography/computed tomography study in the follow-up of prostate cancer
title_short Fibrous dysplasia as a possible false-positive finding in 68Ga-labeled prostate-specific membrane antigen positron emission tomography/computed tomography study in the follow-up of prostate cancer
title_sort fibrous dysplasia as a possible false positive finding in 68ga labeled prostate specific membrane antigen positron emission tomography computed tomography study in the follow up of prostate cancer
topic 68ga-labeled prostate-specific membrane antigen
bone metastasis
false-positive result
fibrous dysplasia
prostate cancer
url http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_111_18
work_keys_str_mv AT andremarcondesbragaribeiro fibrousdysplasiaasapossiblefalsepositivefindingin68galabeledprostatespecificmembraneantigenpositronemissiontomographycomputedtomographystudyinthefollowupofprostatecancer
AT eduardonobregapereiralima fibrousdysplasiaasapossiblefalsepositivefindingin68galabeledprostatespecificmembraneantigenpositronemissiontomographycomputedtomographystudyinthefollowupofprostatecancer
AT mauriciomurcerocha fibrousdysplasiaasapossiblefalsepositivefindingin68galabeledprostatespecificmembraneantigenpositronemissiontomographycomputedtomographystudyinthefollowupofprostatecancer